# Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia

> **NCT01414803** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 180 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **DRUG:** Lipid modification
- **DRUG:** Lipid modification

## Key facts

- **NCT ID:** NCT01414803
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2011-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414803, "Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01414803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*